ISHRAK OMAR 4
4 · AMGEN INC · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
Amgen (AMGN) Director Ishrak Omar Receives Award of 106 Shares
What Happened
- Ishrak Omar, a director of Amgen Inc., received an award of 106.193 shares (reported as code A) on May 5, 2026. The reported acquisition price is $0.00, indicating these are restricted stock units (RSUs) granted rather than a purchase.
Key Details
- Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (timely filing).
- Shares/units granted: 106.193; reported price: $0.00.
- Footnote: The grant includes 418 Dividend Equivalents (DEs) credited to the unvested RSUs under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and a qualifying dividend reinvestment plan. DEs are paid in shares on a one-for-one basis per the vesting schedule, with cash for any fractional share.
- Shares owned after the transaction: not specified in the provided filing excerpt.
Context
- This is a company equity award (RSUs) to a director, not an open-market purchase or sale. Such grants are typically part of compensation and vest over time; they do not by themselves signal buying or selling intent.
Insider Transaction Report
Form 4
AMGEN INCAMGN
ISHRAK OMAR
Director
Transactions
- Award
Common Stock
[F1]2026-05-05+106.193→ 6,693.736 total
Footnotes (1)
- [F1]These shares include 418 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ Andrea A. Robinson, Attorney-In-Fact for Dr. Ishrak|2026-05-07